Morepen Laboratories Ltd consolidated Q4 FY2024-25 net profit lower at Rs. 20.31 crores

Morepen Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2025.

Financial Results (Q4 FY2025) - QoQ Comparison

The company has reported total income of Rs. 470.4647 crores during the period ended March 31, 2025 as compared to Rs. 458.1176 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs. 20.3104 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 26.6885 crores for the period ended December 31, 2024.

The company has reported EPS of Rs. 0.35 for the period ended March 31, 2025 as compared to Rs. 0.49 for the period ended December 31, 2024.

Financials	Q4 FY2025	Q3 FY2025	% Change
Total Income	₹ 470.4647 crs	₹458.1176 crs	2.70%
Net Profit	₹20.3104 crs	₹26.6885 crs	-23.90%
EPS	₹0.35	₹0.49	-28.57%

Financial Results (Q4 FY2025) - YoY Comparison

The company has reported total income of Rs. 470.4647 crores during the period ended March 31, 2025 as compared to Rs.427.3165 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs.20.3104 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.28.7410 crores for the period ended March 31, 2024.

The company has reported EPS of Rs.0.35 for the period ended March 31, 2025 as compared to Rs.0.54 for the period ended March 31, 2024.

Financials	Q4 FY2025	Q4 FY2024	% Change
Total Income	₹ 470.4647 crs	₹427.3165 crs	10.10%
Net Profit	₹20.3104 crs	₹28.7410 crs	-29.33%
EPS	₹0.35	₹0.54	-35.19%

Financial Results (Year Ended FY2025) - YoY Comparison

The company has reported total income of Rs.1829.9395 crores during the Financial Year ended March 31, 2025 as compared to Rs.1704.4033 crores during the Financial Year ended March 31, 2024.

The company has posted net profit / (loss) of Rs.118.0154 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.96.6203 crores for the Financial Year ended March 31, 2024.

The company has reported EPS of Rs.2.20 for the Financial Year ended March 31, 2025 as compared to Rs.1.88 for the Financial Year ended March 31, 2024.

Financials	Year Ended FY2025	Year Ended FY2024	% Change
Total Income	₹1829.9395 crs	₹1704.4033 crs	7.37%
Net Profit	₹118.0154 crs	₹96.6203 crs	22.14%
EPS	₹2.20	₹1.88	17.02%

Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 60.38 as compared to the previous close of Rs. 56.23. The total number of shares traded during the day was 353254 in over 1393 trades.

The stock hit an intraday high of Rs. 60.65 and intraday low of 59.28. The net turnover during the day was Rs. 21214361.00.

Source : Equity Bulls

Keywords

MorepenLaboratories Q4FY25 Q4FY2025 FY2025 ResultUpdate